Safety and Efficacy of LX4211 With Metformin in Type 2 Diabetes Patients With Inadequate Glycemic Control on Metformin

NCT01376557 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

299

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: 75 mg LX4211
DRUG: 200 mg LX4211
DRUG: 400 mg LX4211
DRUG: 200 mg LX4211
DRUG: Placebo

Sponsor

Lexicon Pharmaceuticals